Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Valeria SCANDURRA |
Documents disponibles écrits par cet auteur (3)
Faire une suggestion Affiner la recherche
Epilepsy in Autism Spectrum Disorders: Clinical Aspects and Implications for Treatment / Roberto CANITANO
Titre : Epilepsy in Autism Spectrum Disorders: Clinical Aspects and Implications for Treatment Type de document : Texte imprimé et/ou numérique Auteurs : Roberto CANITANO, Auteur ; Valeria SCANDURRA, Auteur Année de publication : 2008 Importance : p.197-209 Langues : Anglais (eng) Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=670 Epilepsy in Autism Spectrum Disorders: Clinical Aspects and Implications for Treatment [Texte imprimé et/ou numérique] / Roberto CANITANO, Auteur ; Valeria SCANDURRA, Auteur . - 2008 . - p.197-209.
Langues : Anglais (eng)
Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=670 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Glutamatergic agents in Autism Spectrum Disorders: Current trends / Roberto CANITANO in Research in Autism Spectrum Disorders, 8-3 (March 2014)
[article]
Titre : Glutamatergic agents in Autism Spectrum Disorders: Current trends Type de document : Texte imprimé et/ou numérique Auteurs : Roberto CANITANO, Auteur ; Valeria SCANDURRA, Auteur Article en page(s) : p.255-265 Langues : Anglais (eng) Mots-clés : Glutamate Autism Spectrum Disorders Novel treatments Childhood and adolescence Index. décimale : PER Périodiques Résumé : Abstract Glutamate transmission dysfunction has been found in various preclinical models of Autism Spectrum Disorders (ASD), thus the glutamate system is a target for therapeutics. This report reviews current treatments for glutamate dysfunction in ASD models and clinical trials. Antagonists of metabotropic glutamate receptor subtype 5 (mGluR5) have been tested in preclinical models of autism. Black and Tan Bachyuric (BTBR) mice model behavioral phenotypes of the three core diagnostic domains of autism, e.g. social deficits, impaired language and communication, and repetitive behaviors. A significant reduction in repetitive self-grooming was observed after mGluR5 antagonist administration in BTBR mice. SHANK 3 deficient mice which have altered synaptic transmission and plasticity, were administered IGF-1 treatment to reverse these deficits based on the hypothesis that reduced AMPA receptor levels reflect less mature synapses. Clinical trials have been carried out in ASD with glutamate NMDA receptors, but current findings are not sufficient for conclusions on safety and efficacy. Memantine is an NMDA antagonist under investigation in controlled trials that hopefully will provide new insight on its use in autism. Studies using novel treatments with other glutamatergic agents are also underway and encouraging results have been observed with N-acetylcysteine in treating irritability in ASD. En ligne : http://dx.doi.org/10.1016/j.rasd.2013.12.009 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=224
in Research in Autism Spectrum Disorders > 8-3 (March 2014) . - p.255-265[article] Glutamatergic agents in Autism Spectrum Disorders: Current trends [Texte imprimé et/ou numérique] / Roberto CANITANO, Auteur ; Valeria SCANDURRA, Auteur . - p.255-265.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 8-3 (March 2014) . - p.255-265
Mots-clés : Glutamate Autism Spectrum Disorders Novel treatments Childhood and adolescence Index. décimale : PER Périodiques Résumé : Abstract Glutamate transmission dysfunction has been found in various preclinical models of Autism Spectrum Disorders (ASD), thus the glutamate system is a target for therapeutics. This report reviews current treatments for glutamate dysfunction in ASD models and clinical trials. Antagonists of metabotropic glutamate receptor subtype 5 (mGluR5) have been tested in preclinical models of autism. Black and Tan Bachyuric (BTBR) mice model behavioral phenotypes of the three core diagnostic domains of autism, e.g. social deficits, impaired language and communication, and repetitive behaviors. A significant reduction in repetitive self-grooming was observed after mGluR5 antagonist administration in BTBR mice. SHANK 3 deficient mice which have altered synaptic transmission and plasticity, were administered IGF-1 treatment to reverse these deficits based on the hypothesis that reduced AMPA receptor levels reflect less mature synapses. Clinical trials have been carried out in ASD with glutamate NMDA receptors, but current findings are not sufficient for conclusions on safety and efficacy. Memantine is an NMDA antagonist under investigation in controlled trials that hopefully will provide new insight on its use in autism. Studies using novel treatments with other glutamatergic agents are also underway and encouraging results have been observed with N-acetylcysteine in treating irritability in ASD. En ligne : http://dx.doi.org/10.1016/j.rasd.2013.12.009 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=224 Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay / Lucia Pia BRUNO in Journal of Autism and Developmental Disorders, 52-10 (October 2022)
[article]
Titre : Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay Type de document : Texte imprimé et/ou numérique Auteurs : Lucia Pia BRUNO, Auteur ; Francesca FAVA, Auteur ; Margherita BALDASSARRI, Auteur ; Virginia M. SALVATI, Auteur ; Valeria SCANDURRA, Auteur ; Roberto CANITANO, Auteur ; Floriana VALENTINO, Auteur ; Gabriella DODDATO, Auteur ; Rossella TITA, Auteur ; Annarita GILIBERTI, Auteur ; Alessandra RENIERI, Auteur ; Francesca ARIANI, Auteur Article en page(s) : p.4605-4607 Langues : Anglais (eng) Index. décimale : PER Périodiques En ligne : http://dx.doi.org/10.1007/s10803-021-05332-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486
in Journal of Autism and Developmental Disorders > 52-10 (October 2022) . - p.4605-4607[article] Identification of a Novel Pathogenic Variant in the NAGLU Gene in a Child with Neurodevelopmental Delay [Texte imprimé et/ou numérique] / Lucia Pia BRUNO, Auteur ; Francesca FAVA, Auteur ; Margherita BALDASSARRI, Auteur ; Virginia M. SALVATI, Auteur ; Valeria SCANDURRA, Auteur ; Roberto CANITANO, Auteur ; Floriana VALENTINO, Auteur ; Gabriella DODDATO, Auteur ; Rossella TITA, Auteur ; Annarita GILIBERTI, Auteur ; Alessandra RENIERI, Auteur ; Francesca ARIANI, Auteur . - p.4605-4607.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-10 (October 2022) . - p.4605-4607
Index. décimale : PER Périodiques En ligne : http://dx.doi.org/10.1007/s10803-021-05332-x Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=486